申请人:Kowa Co., Ltd.
公开号:US06432957B1
公开(公告)日:2002-08-13
A piperazine compound represented by formula (1):
wherein X is —CH2—, —C(O)— or —CH(CH3)—; R1 is a hydrogen atom or alkyl group; and R2 is a hydrogen atom, alkyl group, hydroxyalkyl group, arylalkyl group, heteroarylalkyl group, carboxyalkyl group, carboxamidoalkyl group, aminoalkyl group or guanidinoalkyl group; an acid-addition salt thereof, or a hydrate thereof. The compound has excellent inhibitory effects on both cell adhesion and cell infiltration and is useful for prevention or treatment of diseases such as allergy, asthma, rheumatism, arteriosclerosis and inflammation.
一种由式(1)表示的哌嗪化合物:其中X为—CH2—、—C(O)—或—CH(CH3)—;R1为氢原子或烷基;R2为氢原子、烷基、羟基烷基、芳基烷基、杂芳基烷基、羧基烷基、羧酰胺基烷基、氨基烷基或胍基烷基;其酸加成盐,或其水合物。该化合物对细胞黏附和细胞浸润均具有优异的抑制作用,可用于预防或治疗过敏、哮喘、风湿病、动脉硬化和炎症等疾病。